The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Metabolic Syndrome

Last updated: November 7, 2018
Sponsor: National Nutrition and Food Technology Institute
Overall Status: Active - Recruiting

Phase

N/A

Condition

Metabolic Syndrome

Diabetes Prevention

High Cholesterol (Hyperlipidemia)

Treatment

N/A

Clinical Study ID

NCT03734835
13678
  • Ages 18-70
  • All Genders

Study Summary

To study the effects of Hesperidin, flaxseed and both together in patients with metabolic syndrome, 100 patients will be randomly allocated to one of following four groups: control group, hesperidin group (2 capsules Hesperidin), flaxseed group (30 gram flaxseed) or flaxseed-hesperidin group (2 capsules Hesperidin and 30 gram flaxseed) for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, metabolic factors will be assessed and compared between groups.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age of 18 to 70 years

  • having 3 of 5 of high blood sugar, hypertension, high TG, high waist circumference,low HD

Exclusion

Exclusion Criteria:

  • pregnancy or lactation

  • history of Cardiovascular disease, Pulmonary disease, Renal disease & Celiac disease;Cirrhosis

  • Following a program to lose weight in recent 3 mo

Study Design

Total Participants: 100
Study Start date:
April 01, 2018
Estimated Completion Date:
March 01, 2019

Connect with a study center

  • National Nutrition and Food Technology Research Institute

    Tehran, Iran (the Islamic Republic Of) 1981619573
    Iran, Islamic Republic of

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.